Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women. 2000

A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
Clinic of Infectious Diseases, University of Bari, Italy.

Information regarding the presence of HIV-1 in the female genital tract is necessary to gain insight into the mechanism of HIV-1 heterosexual transmission. Herein, we present the results of a study on virus isolation and HIV-1 RNA detection from cervicovaginal lavage (CVL) samples from 25 HIV-1 seropositive women. Despite detectable levels of HIV-1 RNA in 88% of CVL samples, HIV-1 was isolated in only four (19%) samples. Although HIV-1 shedding in cervicovaginal secretions is a common event at all disease stages, the recovery of infectious virus in cell cultures appears to be rare; this renders viral isolation in studies aimed to evaluate the infectivity of cervicovaginal secretions relatively useless.

UI MeSH Term Description Entries
D002584 Cervix Uteri The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal. Cervical Canal of the Uterus,Cervical Canal, Uterine,Ectocervix,Endocervical Canal,Endocervix,External Os Cervix,External Os of the Cervix,Uterine Cervical Canal,Cervix,Cervixes,Uterine Cervix,Canal, Endocervical,Canal, Uterine Cervical,Cervix, External Os,Cervix, Uterine,Endocervical Canals,Uterine Cervical Canals
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014621 Vagina The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed) Vaginas
D014776 Virus Cultivation Process of growing viruses in live animals, plants, or cultured cells. Viral Cultivation,Cultivation, Viral,Cultivation, Virus,Cultivations, Viral,Cultivations, Virus,Viral Cultivations,Virus Cultivations
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017201 Virus Shedding The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract (important in INFECTIOUS DISEASE TRANSMISSION, VERTICAL), and intestinal tract. Viral Shedding,Shedding, Viral,Shedding, Virus
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
February 2001, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
November 1997, AIDS (London, England),
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
February 2001, Journal of acquired immune deficiency syndromes (1999),
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
July 2005, Journal of acquired immune deficiency syndromes (1999),
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
August 1995, Cytokine,
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
February 2011, Journal of clinical microbiology,
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
October 1999, Journal of acquired immune deficiency syndromes (1999),
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
July 1993, Journal of acquired immune deficiency syndromes,
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
January 1993, Journal of acquired immune deficiency syndromes,
A Saracino, and M Di Stefano, and J R Fiore, and A Lepera, and D Raimondi, and G Angarano, and G Pastore
December 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Copied contents to your clipboard!